Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Immunology
Impact-faktor: 1.404 5-jähriger Impact-Faktor: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Druckformat: 1040-8401
ISSN Online: 2162-6472

Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v21.i1-3.60
15 pages

The Basis of Immunogenicity of Endocrine Allografts

Mark R. Nicolls
Marilyne Coulombe
Ronald G. Gill
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E. 9th Avenue, Box B-140, Denver, CO 80262


Two signals are required for optimal T-cell activation: the engagement of the antigen-specific receptor and the provision of a second non–antigen-specific inductive signal, or costimulator (CoS). Regarding allograft immunity, two primary pathways of donor antigen presentation can fulfill this two-signal requirement, resulting in cellular immunity to a transplant: (1) "direct" (donor MHC-restricted) presentation in which the antigen-presenting cells (APCs) resident within the transplant directly activate host T lymphocytes and (2) "indirect" (host MHC-restricted) presentation in which host-derived APCs acquire donor antigens that are then presented to host T lymphocytes. It appears that endocrine allografts, such as pancreatic islets and thyroid, are highly dependent on donor-derived APCs, or "passenger leukocytes," to trigger acute graft rejection. Tissue pretreatment aimed at selectively eliminating APCs within endocrine tissues can result in indefinite allograft survival in immune-competent recipients. Although such results implicate the “direct” pathway as the predominant route of host sensitization, the role of donor APCs in rejection appears to be more complex. Recently, we have found that indirect, CD4 T-cell–dependent reactivity can contribute to islet allograft rejection. However, such indirect recognition nevertheless requires donor-derived APCs as a source of antigen. Thus, whereas the donor-type APC is a critical limiting step for initiating islet allograft rejection, such cells can trigger both direct and indirect forms of immune responses that can result in graft rejection. That is, donor hematopoietic cells, rather than tissue parenchymal cells, probably play a major role in providing antigens that stimulate cellular immunity.

Articles with similar content:

Immunological Protection Against Mycobacterium tuberculosis Infection
Critical Reviews™ in Immunology, Vol.26, 2006, issue 6
Yasunobu Yoshikai
Molecular Interactions Between Dendritic Cells and Salmonella: Escape from Adaptive Immunity and Implications on Pathogenesis
Critical Reviews™ in Immunology, Vol.25, 2005, issue 5
Mirentxu I. Iruretagoyena, Alexis M. Kalergis, Jaime A. Tobar, Susan M. Bueno
Toll Like Receptor-2 Signaling in Mycobacterium Tuberculosis Infection−A Double-Edged Sword
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 3-4
Sadhna Sharma, Monika Sharma
Endothelial Injury, Alarmins, and Allog raft Rejection
Critical Reviews™ in Immunology, Vol.28, 2008, issue 3
Deepak A. Rao, Jordan S. Pober
Induction of Cytokines and Chemokines by Toll-like Receptor Signaling: Strategies for Control of Infammation
Critical Reviews™ in Immunology, Vol.30, 2010, issue 1
Goutam Gupta, Ahmet Zeytun, Anu Chaudhary, Paige Pardington, R. Bruce Cary